1 |
Butner JD, Wang Z. Predicting immune checkpoint inhibitor response with mathematical modeling. Immunotherapy 2021;13:1151-5. [PMID: 34435504 DOI: 10.2217/imt-2021-0209] [Reference Citation Analysis]
|
2 |
Grassberger C, Ngwa W. Modelling treatment-response rates. Nat Biomed Eng 2021;5:295-6. [PMID: 33864036 DOI: 10.1038/s41551-021-00717-w] [Reference Citation Analysis]
|
3 |
Zakaria R, Radon M, Mills S, Mitchell D, Palmieri C, Chung C, Jenkinson MD. The Role of the Immune Response in Brain Metastases: Novel Imaging Biomarkers for Immunotherapy. Front Oncol 2021;11:711405. [PMID: 34765539 DOI: 10.3389/fonc.2021.711405] [Reference Citation Analysis]
|
4 |
Anaya DA, Dogra P, Wang Z, Haider M, Ehab J, Jeong DK, Ghayouri M, Lauwers GY, Thomas K, Kim R, Butner JD, Nizzero S, Ramírez JR, Plodinec M, Sidman RL, Cavenee WK, Pasqualini R, Arap W, Fleming JB, Cristini V. A Mathematical Model to Estimate Chemotherapy Concentration at the Tumor-Site and Predict Therapy Response in Colorectal Cancer Patients with Liver Metastases. Cancers (Basel) 2021;13:444. [PMID: 33503971 DOI: 10.3390/cancers13030444] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Guo H, Zhang T, Yu Y, Xu F. Cancer Physical Hallmarks as New Targets for Improved Immunotherapy. Trends Cell Biol 2021;31:520-4. [PMID: 33926772 DOI: 10.1016/j.tcb.2021.03.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
6 |
Gok Yavuz B, Hasanov E, Lee SS, Mohamed YI, Curran MA, Koay EJ, Cristini V, Kaseb AO. Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:1195-207. [PMID: 34595140 DOI: 10.2147/JHC.S322289] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|